AptaBio's Series B Round

AptaBio raised a round of funding on July 22, 2016.

AptaBio (압타바이오) is a South Korean pharmaceutical company focused on the discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs.…

Articles about AptaBio's Series B Round: